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Improving our understanding of sleep physiology and pathophysiology is an important goal for both medical and general wellness
reasons. Although the gold standard for assessing sleep remains the laboratory polysomnogram, there is an increasing interest
in portable monitoring devices that provide the opportunity for assessing sleep in real-world environments such as the home.
Portable devices allow repeated measurements, evaluation of temporal patterns, and self-experimentation. We review recent
developments in devices designed to monitor sleep-wake activity, as well as monitors designed for other purposes that could
in principle be applied in the ﬁeld of sleep (such as cardiac or respiratory sensing). As the body of supporting validation data
grows, these devices hold promise for a variety of health and wellness goals. From a clinical and research standpoint, the capacity
to obtain longitudinal sleep-wake data may improve disease phenotyping, individualized treatment decisions, and individualized
health optimization. From a wellness standpoint, commercially available devices may allow individuals to track their own sleep
with the goal of ﬁnding patterns and correlations with modiﬁable behaviors such as exercise, diet, and sleep aids.
1.Introduction
The laboratory polysomnogram (PSG) has long been the
gold standard for assessing sleep physiology in health and
disease. The PSG has proven most useful for the diag-
nosis and treatment of obstructive sleep apnea (OSA),
althoughlesscommondisordersarealsoreadilyidentiﬁedby
laboratory PSG, including narcolepsy, rapid-eye-movement
(REM) sleep behavior disorder, non-REM parasomnias, and
periodic limb movements of sleep. The diagnostic criteria
for certain sleep disorders, such as restless legs syndrome
and insomnia, are purely clinical. For insomnia in particular,
exclusive reliance on self-reported complaints presents two
important challenges in understanding this common dis-
order. First, it is not uncommon to observe a mismatch
between the subjective report of sleep-wake durations and
the objective ﬁndings of the PSG. Second, the lack of
objectivedataconstrainsthecapacitytophenotypeinsomnia
patients, a limitation that has implications ranging from
epidemiology studies to the development of therapeutic
strategies.
Despite the clear utility of PSG in clinical sleep medicine,
issues of cost and inconvenience have motivated the devel-
opment of portable devices capable of evaluating sleep in
the home. Clinical home testing is currently targeting sleep
disordered breathing, and the data supporting the use of
home sleep apnea devices has been reviewed recently [1, 2].
Although, to date, home-based sleep measurements have
focused on sleep apnea diagnostics, patients with insomnia
may also beneﬁt from advances in home-sleep-monitoring
devices. Wrist actigraphy, which measures limb movement,
has been used for several decades in various contexts, includ-
ing in patients with insomnia; however, actigraphy is not
widely used clinically. For example, recent practice param-
eters suggest actigraphy as an option for circadian rhythm
disordersandpotentiallyforadjunctiveassessmentofinsom-
nia [3]. However, the diagnostic classiﬁcations of insomnia
provided by the American Academy of Sleep Medicine and2 ISRN Neurology
by the psychiatric Diagnostic and Statistical Manual do not
includeanyobjectivecriteria.Despitetheextensivepublished
experience with wrist movement-based monitors in research
settings [4, 5], actigraphy does not enjoy wide clinical use
because of limited utility outside of circadian rhythm
disorders, which are often evident by clinical history alone.
Nevertheless, commercially available movement-based sleep
monitors are growing increasingly common in the consumer
wellness market. The utility of such devices in a medically
unregulated fashion remains uncertain.
The wellness and clinical markets share an interest for
improved metrics of “real-world” sleep patterns. Longitu-
dinal home monitoring avoids certain limitations of the
laboratory PSG, such as the atypical sleeping environment
and the single-night snapshot. Sleep is a dynamic process
that varies from day to day, and hence it is important to
measure multiple nights of sleep for medical, research,
and wellness reasons. Home monitoring devices oﬀer the
potential to provide a more realistic platform in which many
nights of sleep data can be captured. Longitudinal data
is likely to prove invaluable for the discovery of intrinsic
patterns of sleep variability or to correlate sleep with the
timing of various other activities such as exercise, naps,
food, caﬀeine, alcohol, and stress. Since each of these
“other activities” can vary from day to day, complex eﬀects
and interactions are expected to occur, which creates the
need for large data sets to identify correlations with sleep.
Quantifying sleep in relation to these diverse factors can
only be accomplished through longitudinal data, with the
clinical goal of individualized evaluations and treatment
strategies. The personal wellness goal of sleep-monitoring
in order to optimize health also stands to be achieved
through longitudinal monitoring and self-tracking. This
goal is served by portable monitoring in a variety of contexts
outside of the ﬁeld of sleep medicine (for review, see [6]).
The present paper reviews recent developments in the
area of devices that can be used for home-based sleep
assessment, some of which are currently available for
direct purchase in the wellness market. Devices developed
explicitly for sleep quality monitoring are reviewed, as are
devices developed for other reasons that could potentially
be adapted for sleep-monitoring. The list is not intended
to be exhaustive, and it is likely that the ﬁeld will continue
to expand rapidly as new devices are introduced. We do
not review devices used for detection or diagnosis of sleep
apnea [1], nor do we review standard actigraphy devices
[7]. When available, validation information is provided (see
Section 7 for further comments on the metrics of sensitivity,
speciﬁcity, and accuracy). These devices are grouped into
categories based on the type of data collected. For each
device, listed alphabetically within category, the key features
are evaluated including availability of published validation
studies. Finally, we discuss a research agenda for the ﬁeld of
home-based sleep-monitoring. This paper is not intended to
endorse any particular device or to advise readers medically
regarding diagnostics or therapeutics; in fact it is important
to recognize that nonrefreshing sleep can be associated with
numerous medical and psychiatric conditions, and physician
consultation is suggested for concerned readers.
2. Sleep-MonitoringBasedon
BrainActivitySignals
2.1. iBrain (NeuroVigil). This device consists of headgear
that records a single frontal lead EEG. The algorithm used
to process the frontal EEG is based originally on work done
in zebra ﬁnch birds, in which 84% accuracy was obtained
when compared to manual sleep-wake scoring in that species
[8]. The company web site indicates ongoing human studies;
however, no validation studies in humans are currently
available. Data from the device can be updated via a USB
drive which also charges the device. The device can record
multiple nights of data.
2.2. Zeo (Available for Consumer Purchase). This device con-
sists of an elastic headband with fabric sensors on the
forehead that detect a combination of electroencephalo-
gram (EEG), frontalis muscle electromyogram (EMG), and
electrooculogram (EOG) signals. The headband broadcasts
wirelessly to either an alarm clock receiver station or to an
iPhone for analysis. The main advantage of the Zeo is the
capacitytomonitorsleepovertimewithrelativeease.Indeed,
the headband sensor can be used daily for several months
before the sensor pads require replacement.
A proprietary neural network model uses the data
streams to render classiﬁcations of wake, light NREM, deep
NREM, and REM sleep in 30-second epochs. Deep NREM
sleep corresponds to slow wave sleep or stage N3. The term
“deep”isoftenlinkedtothisstagebecauseoftheconspicuous
high-amplitude and low-frequency EEG signal pattern and
because awakening from this stage of sleep is most diﬃcult.
Although the Zeo algorithm assigns greater weight in their
sleep quality index to this stage of sleep, there is little
evidence in the literature that the amount of “deep” sleep
correlates with feeling refreshed. Deep sleep has been shown
tocorrelatewith“homeostatic”sleeppressure:thelongerone
has been awake, the more sleep pressure accumulates and
the more deep sleep is observed during subsequent recovery
sleep.
The light NREM sleep class is actually a combination of
two stages of NREM sleep known as N1 and N2. However,
these are fundamentally diﬀerent states, with the latter
containing two classic features of sleep, known as sleep
spindles and K-complexes, while the former lacks these
features and is instead characterized by mild slowing of the
EEG (relative to high-frequency and low-amplitude EEG
signals typical of wakefulness). In fact, stage N2 represents
the majority of sleep time in a normal individual. It is worth
emphasizing that there is no clinical or biological basis for
combining these two stages, and the potentially negative
connotation of the term “light” may give users the false
impression that sleep scored in this category is necessarily
abnormal. Although excessive stage N1 sleep may indicate
sleep fragmentation (of any cause), this is not the case for
stage N2. There is no way to distinguish N1 and N2 usingISRN Neurology 3
this device, due to combining N1 and N2 sleep into a single
category.
Zeo recently published a validation study of their sleep
staging algorithm, which was initially optimized using a
group of healthy adults aged 21–60 (67% male) and then
tested in a separate group of 26 healthy adults aged 19–60
years (50% male) [9]. Subjects underwent laboratory PSG
with simultaneous headband monitoring, which showed
∼75% agreement on epoch-by-epoch scoring across all
sleep-wake stages. Of note, the two human experts scoring
the PSG data showed only 83% agreement, which can be
viewed as an apparent upper limit of performance for any
automated scoring algorithm. This modest agreement is
similar to prior literature and serves as a reminder that
sleep stage scoring is characterized by substantial uncer-
tainty. When considering each PSG-scored sleep-wake stage
individually, Zeo correctly identiﬁed 71% of deep NREM
sleep and 64% of wake, while it was better at detecting
light NREM and REM sleep (86% each). Another way to
understand the accuracy of the classiﬁcation is to ask how
likely a stage reported by the Zeo matches that deﬁned by
the PSG scoring. For example, there was a 75% chance that
an epoch scored as REM by the Zeo was correct. When Zeo
was mistaken about REM sleep, the most likely PSG-deﬁned
stagestobemisclassiﬁedasREMwerelightNREMandwake.
Epochs scored as deep NREM had a 69% chance of being
correct, while those scored as wake or REM sleep each had
∼85% chance of being correct.
The extent to which the classiﬁer algorithm retains accu-
racy with patients suﬀering from medical, neurological,
psychiatric,or sleepdisordersis unknown. Onemight expect
certain medications to alter accuracy, due to eﬀects on the
EEG, EMG, and EOG (especially neuroactive medications).
In addition, the eﬀects of caﬀeine, smoking, and alcohol (all
of which are known to aﬀect sleep physiology) also remain
unknown.Zeodoeshavetheoptionforresearcherstopursue
oﬀ-line postprocessing of the recorded signals.
3.Sleep-MonitoringBasedon
Autonomic Signals
3.1. Heally Recording System. The Heally system consists of
a shirt with a combination of embedded sensors and wired
adhesive electrodes that measure respiratory and cardiac
physiology, as well as ports for optional EMG and EOG
electrodes [10]. A small study of six healthy male subjects
was conducted at home over multiple nights, in which sleep
versus wake was scored according to nonvalidated criteria (a
humanscorerclassiﬁedsleep-wakestateusing‘acombination
of video, EOG and EMG signals). Like wrist actigraphy, the
shirt overestimated total sleep time as well as the number
of brief awakenings, compared to the human scoring.
The accuracy across subjects was modest at approximately
80% agreement with human scoring, similar to accuracies
obtained with limb actigraphy [10].
3.2. M1 (SleepImage). This medical device consists of a small
processing unit and wire electrode that attaches to the chest
via adhesive pads. Data signals stored locally in the device
include electrocardiogram (ECG), actigraphy, and body
position. The trunk actigraphy signal is used to determine
total sleep time, sleep eﬃciency, and the number of awak-
enings that occur within sleep. The signals are subjected to
oﬀ-line analysis through the SleepImage web site. The ECG
component is used to compute cardiopulmonary coupling
frequencies, a metric that consists of a combination of
respiratory-driven heart rate variability (autonomic func-
tion) and ﬂuctuations in the R-wave amplitude that relate to
mechanical changes of breathing (position of the heart and
lung tissue relative to the skin surface) [11]. This algorithm
distinguishes “stable” versus “unstable” NREM sleep, using
the cardiopulmonary coupling metric rather than the brain,
eye, and muscle activity used for the standard classiﬁcation
of N1, N2, N3, and REM sleep. The relationship between
“stable” and “unstable” NREM sleep and conventional EEG-
derived sleep stages is described next.
Stable NREM is associated mainly with stage N3 but also
includes portions of N2 and is associated with a coupling
frequency in the range of the normal respiratory rate, which
is around 0.3Hz. This pattern is known as high-frequency
coupling (HFC). Unstable NREM sleep is associated mainly
with stage N1 but also portions of stage N2, especially when
N2sleepisfragmentedand/orthe“cyclicalternatingpattern”
is seen [12]. This pattern is associated with coupling in a
lowerrange(0.1Hz)andisknownaslow-frequencycoupling
(LFC). REM sleep and wakefulness produce similar coupling
frequencies,duetosimilarlyirregularbreathing.Thispattern
is known as very low-frequency coupling (VLFC) and occurs
at frequencies under 0.01Hz.
When sleep apnea is present, the contribution of the
LFC component is increased, known as elevated LFC or e-
LFC. Within this e-LFC metric, if the frequency is variable,
this is known as broad-band coupling and is associated with
obstructive sleep apnea. This pattern corresponds to the
observation that obstructive apnea events typically have
variable cycle lengths. However, when the dominant e-LFC
values are very similar over time, this is known as “narrow
band coupling” and is associated with central sleep apnea
which typically has a short and “metronomic” cycle length.
Thus, although the device is not approved for the diagnosis
of sleep apnea, within known sleep apnea patients some
distinction can be achieved between obstructive and central
phenotypes [13]. It is worth noting that sleep that is highly
fragmented for a variety of reasons may be dominated by a
high percentage of the night spent in the LFC pattern.
The M1 can be used for 5–7 nights of recording on two
disposable button batteries. The raw ECG data is stored
locally in the device and is extracted oﬀ-line for analysis.
Early validation studies took advantage of the fact that
the coupling algorithm can be applied to any ECG signal,
such as those obtained routinely in overnight PSG studies.
Analysis of the large Sleep Heart Health Study database
showed correlations of HFC and LFC with important factors
such as stroke and hypertension [14]. Subsequent studies
showed correlations of coupling metrics with depression and
ﬁbromyalgia [15, 16].4 ISRN Neurology
One limitation of the device is that certain patient
populations may not be amenable to ECG analysis, including
those with certain types of arrhythmias and potentially
patients with autonomic dysfunction. Also, trunk actigraphy
such as that provided by this device does not have as
much supporting data, compared to the traditional wrist
actigraphy, for estimating sleep and wake.
4. Sleep-MonitoringBasedonMovement
4.1. Fitbit (Available for Consumer Purchase). The Fitbit
monitor is a small device that can be worn on the wrist,
clipped to clothing, or carried in a pocket. The features
include a pedometer and altimeter (to count steps or hills
climbed), a calorie counting feature (extrapolated from the
estimateofstepswalked),movementdetectionbyactigraphy,
and a clock. The analysis of movement yields standard sleep-
related metrics such as a distinction between sleep and wake,
total sleep time, sleep latency, and an “arousal index” based
onepisodesofmovementduringpresumedsleeptime.There
are no published validations of the accuracy of the sleep-
wake metrics of the Fitbit compared to PSG or to standard
actigraphy watch devices.
4.2. Lark (Available for Consumer Purchase). The Lark device
is a wrist-watch actigraphy monitor that features a silent
vibrating alarm. Actigraphy metrics include total sleep
duration, sleep latency, and a “sleep quality index” based
on movements. However, there are no published validation
reports comparing Lark-derived measures with standard
wrist actigraphy or PSG data. The device currently requires
an iPhone or iPad or iTouch to visualize the data, although
the web site indicates that an Android platform is under
development.
4.3. Sleep Cycle Alarm (Available for Consumer Purchase).
The Sleep Cycle alarm clock is an iPhone application that
uses the built-in accelerometer of the iPhone to monitor
movement during the night. The iPhone is placed near one’s
pillow. The application reports graphs of total sleep time and
a distinction between light sleep, deep sleep, and wake. There
are no available studies of the device to validate this analysis
of sleep. The application also has a smart-alarm feature to
wake users within thirty minutes of their ﬁnal alarm by
detecting periods of light sleep based on movement. Like
the other devices making this smart-alarm claim, supporting
validation studies are not available.
4.4. SleepTracker (Innovative Sleep Solutions) (Available for
Consumer Purchase). T h eS l e e p T r a c k e rd e v i c ei saw r i s t
watch that records movement based on actigraphy. Like
similarmovement-baseddevices,thewebsiteclaimsasmart-
alarm feature that determines optimal points within sleep
to awaken to feel refreshed. The watch has audio-alarm and
vibrating-alarm options. Sleep data can be viewed through
the web site following USB upload, including total sleep
time and a metric of “sleep quality” based on movement.
Although there are no published validation studies of the
smart-alarmfeatureorthesleep-wakeaccuracy,thecompany
has performed testing in 18 adults who underwent simulta-
neous sleep laboratory monitoring for suspected sleep apnea
(unpublished data, personal communication with Lee Loree,
owner). In this study, the device was >90% accurate in
detecting events of sleep disruption, but the relationship of
the detected events to clinically deﬁned sleep parameters is
untested.
4.5. Up (Jawbone) (Available for Consumer Purchase). The
UpmonitorbyJawboneisabracelet-likedevicethatinteracts
with the iPhone. The device serves as a pedometer, and
although it reports a distinction between “deep” and “light”
sleep, there are no published validation studies that compare
the device to PSG or to wrist actigraphy, and even standard
actigraphy algorithms do not typically allow such a distinc-
tion. The device also includes a smart-alarm feature that
claimstoawakentheweareratthe”optimal”time,but,again,
this commonly reported feature lacks published validation.
4.6. WakeMate (Available for Consumer Purchase). Wake-
Mate is a wristband device that transmits actigraphy data to
as m a r tp h o n et or e p o r tb a s i cs l e e pm e t r i c ss u c ha st o t a l
sleep time, sleep latency, number of awakenings, and a “sleep
quality” score based on movements. Compatible interfaces
include iPhone, Android, and Blackberry phones. Like the
above devices, it also makes the smart-alarm claim to
determine the optimal wake time within a window ending in
the ﬁnal alarm setting. The website indicates that the device
is 95%–98% as accurate as standard actigraphy. However,
supporting validation data is not available for either of these
claims.
5.Bed-Based SleepMonitors
5.1. Air Cushion. This is a thin, air-ﬁlled cushion designed to
bepositioned ontopofamattress[17].Thepressure-sensing
pad records heart rate, respiration rate, snoring, and body
movement. An automated sleep staging algorithm using
heart rate and movement signals was developed based on 27
overnight recordings from eight university students who had
no subjective sleep complaints. The algorithm demonstrated
the following agreement with PSG data: 82.6% for NREM
sleep, 38.3% for REM sleep, and 70.5% for wake. As is
commonly the case with autonomic metrics, REM sleep and
wake were diﬃcult to distinguish.
5.2. EarlySense Mattress. This device is a piezoelectric sensor
that is placed under a mattress. The system measures
respiration, heart rate, snoring, coughing, and movement. In
astudyavailableontheirwebsiteof40childrenand16adults
(who were being evaluated for sleep complaints), a Bayesian
classiﬁer algorithm that combined features of respiration
with movement signals distinguished sleep versus wake with
modest accuracy compared to concurrent PSG scoring. On
an epoch by epoch basis, sleep was detected with a sensitivity
of 84% but a speciﬁcity of only 30% (compared to wake);
wake was more accurately identiﬁed (sensitivity of 68%ISRN Neurology 5
and speciﬁcity of 80%). Further distinction of REM versus
NREM sleep was also described, but statistics of accuracy are
not presented. However, REM was reportedly misassigned to
periods of light NREM sleep and adjacent wake epochs.
5.3. Emﬁt Bed Sensor. This system consists of Emﬁt foil
electrodes placed underneath a foam mattress which record
movement, respiratory rate, and heart rate data [18–20].
These data streams were then subject to machine learning
algorithms to optimize agreement with human PSG scoring
in a sample of 17 healthy adults. The mattress algorithm
showed an agreement of 71% with PSG data on an epoch by
epochbasis[19].WakeandREMsleepweremostchallenging
to distinguish, as these two states were most often misclassi-
ﬁed. In a similar study using the Emﬁt foil electrodes, sleep
staging of eleven healthy female participants was moderately
accurate compared to PSG, with an agreement of 76% [18].
In a separate study of nine females, the Emﬁt bed sensor was
found to have a 79% agreement with PSG data in determin-
ing wake, NREM, and REM sleep states, but REM sleep was
again diﬃcult to classify [20].
5.4. Home Health Station (TERVA). T h eH o m eH e a l t hS t a -
tion is a comprehensive system intended to be set up in a
patient’s home to record and display blood pressure, axil-
lary temperature, respiration rate, heart rate, activity, and
subjective behavioral diary entries [21]. The system includes
astatic-charge-sensitivebedengineeredbyBiomattMonitor-
ing systems, which measures heart rate, respiration rate, and
time spent in “quiet” sleep based on movement data. Pre-
vious studies have found the accuracy of the static-charge-
sensitive bed to be between 86% to 98% for classifying wake
versus sleep [22]. In addition, the bed sensor has been used
to detect sleep apnea: it detected sleep-disordered breathing
during 4% of the night in healthy patients compared to 43%
of the night in patients with known sleep apnea [23, 24].
5.5. Linen Sensor. This system consists of electrodes embed-
ded in the pillow case as well as the linens near the foot of
the bed [25]. Validation was conducted in 30 patients under-
going sleep evaluation for a variety of clinical reasons, as
well as six healthy subjects. Data quality was a concern in
their study, as 20% of the recording time was not usable due
to excess movement and/or poor contact with the sensors. In
the six healthy subjects, the bed sensor classiﬁed 82% of the
nightasNREMsleepand19%ofthenightasREMsleep,and
thiswasrelativelyaccuratecomparedtostandardPSG,which
classiﬁed 78% and 23% of night as NREM and REM sleep,
respectively.Thenumberofarousals(whichwerenotdeﬁned
in the paper) was underestimated compared to standard PSG
data.
5.6. SleepMinder (BiancaMed). This device is a radiofre-
quency monitor that uses 5.8GHz frequencies to detect
body movements [26]. The SleepMinder was studied by
placing the sensor above and lateral to the bed, such as on a
bedside table. It was most accurate when placed within
0.5 meters of the bed, with a maximum distance of 2.5
meters. Distinguishing sleep and wake showed 78% accuracy
in a population of 153 subjects who underwent PSG
monitoring for suspected sleep apnea. Total sleep time was
overestimated, which is commonly the case with movement
detection by wearable actigraphy devices. The device per-
formance was less accurate in distinguishing wake, REM,
and stage N1 sleep but reported 96% accuracy in classifying
slow wave sleep. In a separate study of 176 patients who
underwent overnight PSG monitoring for suspected sleep
apnea, the device was able to classify subjects with versus
withoutsleepapnea,basedonacutoﬀvalueofAHI=15,with
a sensitivity of 89% and a speciﬁcity of 92% [27].
5 . 7 .T o u c h - F r e eL i f eC a r e( T L C )S y s t e m .The TLC system is
a bed sensor that can transmit information for remote mon-
itoring. This device can be placed underneath any standard
mattress and wirelessly transmits heart rate, respiratory rate,
and movement data. A sleep “quality score” is generated
based on a combination of sleep duration, restlessness, heart
rate, and breathing rate. However, validation studies of this
sleep quality metric are not available.
6. Other Devices with Potentialfor
Sleep Monitoring
6.1. BioHarness (Zephyr). This vest-like device is strapped
across the chest and records respiration rate, heart rate, skin
temperature,motoractivity,andbodyposition.Thedatacan
be wirelessly transferred for remote monitoring.
6.2. HealthVest (SmartLifeTech). This is a one piece garment
withelectrodesembeddedintheshirt.Respirationrate,heart
rate, and body position can be measured and monitored
remotely.
6.3. LifeBed (Hoana). This is a bed used in clinical settings
that displays and records respiration and heart rate, and it
also alerts caretakers when a patient is out of bed.
6.4. LifeShirt (VivoMetrics, Rae Systems). This monitor is
a form-ﬁtting garment that measures multiple aspects of
respiratory and cardiac physiology, movement, skin temper-
ature, and body position, through a combination of sensors
embedded in the fabric in combination with either dry [28]
oradhesiveelectrodes[29],includingthecapacityforremote
monitoring by wireless transmission. There are optional
ports for extending monitoring to other specialized signals
such as oximetry and blood pressure. Although the authors
describe preliminary ﬁndings regarding the use of the shirt
for sleep staging, no validation data is currently available.
6.5. Magic Vest (Foundation Don Gnocchi). T h ev e s ti sa
form-ﬁtting combination of cotton and lyrica to facilitate
a close connection between the skin and nonadhesive ECG
electrodes.TheECGsignaltrackingwasreliablefordetecting
normal and abnormal rhythms compared with standard6 ISRN Neurology
ECG[30].Theremovabletransmitterattachestothevestand
is about the size of a cell phone.
6.6. Radiofrequency Monitor. Radiofrequency monitors have
been developed to detect movements of the sleeping subject
as a means for unobtrusive monitoring. Li et al. studied the
useofmicrowavebandsignals(26.5–40GHz)[31],whichare
often used in radar detection. An antenna underneath the
bed transmits radiofrequencies to a nearby receiver (i.e.,
a laptop) and allows long-term, overnight respiration and
heart rate monitoring. The accuracy of the device in measur-
ing heart rate was about 80% compared to ﬁnger tip pulse
sensor, depending on body position. Of note, the accuracy
of heart rate determination was compromised by nonsupine
body position. The system is proposed as a way to monitor
patients at home for sleep apnea, but such algorithms have
yet to be developed.
6.7. SenseWear Armband (BodyMedia). This device uses a
combination of sensors including an accelerometer as well
as sensors for heat ﬂux, temperature, and galvanic skin
response. Heart rate variability, body temperature, and other
recoded measurements are used to determine wake, sleep
onset, and total sleep time. In a small study on self-identiﬁed
normal sleepers available on their web site, the armband
agreed 85.3% of the time with PSG data in determining sleep
versus wake states.
6.8. SmartShirt (Sensatex). The SmartShirt is a cotton tee-
shirt which uses sensors inside the fabric to measure and
transmit real-time data of heart rate, body temperature, and
movement.
6.9. Shirt Monitor (Universidad Carlos III de Madrid). This
smartshirtcontainsembeddedelectrodestomeasurecardiac
and pulmonary physiology and also includes a global-
positioning system. Body temperature and position as well
as geographic location can be monitored, the latter feature
having high enough spatial resolution for application to
hospital patients. An extended version of the device uses
imbedded electrodes to monitor and wirelessly transmit vital
signs as well as body position and temperature. The shirt is
machine washable.
6.10. Smart Shirt (Numetrex). This line of clothing contains
sensing ﬁbers knitted into the fabric. Sensors record heart
rate for viewing on the accompanying watch receiver.
6.11. V-Patch and Aingeal Devices (Intelesens). Intelesens
develops wearable vital sign monitors for home and hospital
use. The V-patch is an adhesive device that records 3-lead
EKG for up to 7 days. The Aingeal is an adhesive device
thatrecordscardiac,respiratory,actigraphy,andtemperature
metrics for up to 48 hours of monitoring in hospitalized
patients via a nearby bay station.
6.12. Wealthy (http://www.wealthy-ist.com/). This device is
a tight-ﬁtting garment which uses impedance pneumog-
raphy to determine respiration, piezoresistive sensors and
accelerometers to determine movement and position, as well
assensorstotrackbodytemperatureandheartrate.Theshirt
can store data locally or transmit data via bluetooth.
6.13. WristCare (Vivago). This wrist device has a four-day
subject-speciﬁc activity adaptation period after which it
tracks movement,skin temperature,andskin conductivityas
well as the location of a patient in the hospital and remotely
transmits the data. The device was designed as an automatic
alarm device for the elderly and chronically ill. In a study
of 28 adults, WristCare overestimated total sleep time by 59
minutes (whereas wrist actigraphy only overestimated total
sleep time by 41 minutes) in comparison to PSG data [32].
6.14. Wrist Device (AMON). This device is a wristband
which remotely transmits heart rate, blood pressure, oxygen
saturation, and skin temperature. In addition, it has an
a c c e l e r o m e t e ra n dc a nf u n c t i o na sa na u t o m a t i ca l a r m[ 33].
The device was tested in 33 healthy adult volunteers during
wakefulness; compared to standard laboratory devices, it had
varying degrees of accuracy when measuring blood pressure,
oxygen saturation, and heart rate [33].
6.15. Zio (http://www.irhythmtech.com/). The Zio consists of
a small patch with two electrodes worn on the chest that
enables cardiac monitoring for up to fourteen days. The
disposable patch is intended for clinical use in patients
with cardiac complaints, similar to a Holter monitor. Zio is
designed to record cardiac arrhythmias and heart rate.
7. Discussion
Wearable monitors and passive oﬀ-body sensors are grow-
ing in popularity as novel strategies for recording and
transmitting various physiological signals [6, 34, 35]. Their
medical and wellness applications are vast and include the
measurement of sleep patterns and potentially sleep quality.
However, research must parallel this expanding arena to
ensure appropriate validation studies and understanding of
each device’s limitations in order to maximize the utility of
homemonitoring.Validationisacostlyandtime-consuming
process, and we discuss here various considerations for the
design and testing of home sleep monitors, in hopes of
providing a research agenda going forward. Peer reviewed
studies remain the gold standard in the biomedical commu-
nity, yet the claims of health and wellness devices have not
been universally held to similar standards. This is crucial in
the ﬁeld of sleep monitors, since disturbed or nonrefreshing
sleep may be associated with a number of medical and psy-
chiatric disorders and may warrant physician consultation.
We propose topics here to consider as a framework for a
research agenda in this expanding ﬁeld.
7.1. Hardware Considerations in Sleep-Monitoring. The two
major considerations are cost and comfort, as these may
be the main factors limiting the scope of implementation.
From a cost perspective, both up-front costs and ongoing
costs (disposable parts or software/web site access) should beISRN Neurology 7
considered. The part of the body involved in contact-based
devices (headband, wristband, shirt, etc.) may inﬂuence fac-
tors such as comfort and the integrity of recording. Whether
the device can fall oﬀ or be inﬂuenced by subject placement
should be considered—importantly, these factors may diﬀer
from person to person. Battery life and method/frequency
of recharging may also play a role in consumer acceptance,
especially for devices designed for long-term repeated mon-
itoring. Finally, it is critical to consider the resilience to
various factors present in the sleep environment, such as
body movements, sweating, temperature, humidity, and the
bed partner (e.g., the bed partner’s movements, sounds, or
sleep disorders may inﬂuence the data collected).
7.2. Software Considerations in Sleep-Monitoring. The main
consideration in sleep-monitoring software is ease of use.
The manner of data access may inﬂuence user acceptance.
In some cases, the data is processed for output analytics
but not stored in its primary form. This has advantages of
minimizing data storage needs and may be optimal for real-
time analysis and use in the ﬁeld. Although storing the raw
data for oﬀ-line analysis has the advantage of facilitating
algorithm improvements, the need for storage space and/or
frequent uploading to a server may be cumbersome. Given
the wide variety of sleep problems and comorbidities, it may
be diﬃcult if not impossible to have a single algorithm that
is applicable across diverse populations, and thus it seems
highly useful to have the raw data available for ongoing
improvements.
7.3. Utility of Objective, Longitudinal Monitoring. The clin-
ical paradigm of monitoring in sleep patients involves two
main strategies: the laboratory PSG and the home diary. The
PSG is information rich but has serious limitations of the
unnatural environment and the single-night snapshot. The
diary approach captures a person’s experience in their home
environment in a longitudinal manner but lacks objectivity.
Home sleep monitors oﬀer the potential to bridge these
two extremes by providing some objective measures over
time, ideally in parallel with subjective diary reports. In this
way, patterns may be revealed in sleep and symptoms at
the individual level. The longitudinal aspect allows analysis
over multiple time scales, as certain people may have
ﬂuctuations in their sleep or symptoms over days, weeks,
months,seasons,menstrualcycles,andsoforth.Totheextent
that variability can be found, it then becomes possible to
link this variability to behaviors such as caﬀeine, alcohol,
medications, stress, and exercise—in principle any factor the
individual may care to measure in hopes of ﬁnding sleep
correlations. If correlations can be identiﬁed, this opens the
opportunity to implement personalized behavioral modiﬁ-
cation plans to optimize sleep. For some individuals, certain
medical or psychiatric treatment may be undertaken to
improve sleep, and a home monitor may provide an adjunc-
tive outcome measure in parallel with subjective response.
There is even data to suggest that simply providing feedback
to individuals with sleep problems, through objective sleep
measurements,canimprovesubjectivesleepcomplaints[36].
Finally, from a research and progress standpoint, having the
capacity to add objective sleep measurements holds promise
forimprovingtheabilitytophenotypesleepdisorderssuchas
insomnia that currently have purely subjective criteria. Such
improvements could theoretically contribute to improved
understanding of which types of treatments (prescriptions
or alternative therapies or behavioral interventions) may be
most beneﬁcial.
7.4. A Comment on Device Validation. Validating a home
sleep monitor involves comparing the performance to some
other measurement. When this comparison involves the
gold standard laboratory PSG, which is scored manually
by experienced technicians, it is important to recognize
that this gold standard is itself imprecise. Depending on
the study, the interscorer reliability may be approximately
85%. This sets an upper limit on what can be expected
of an automated algorithm (e.g., see the validation study
of the Zeo device, in which two human scorers were used
[9]). Furthermore, scoring reliability, and by extension,
automated device scoring, may be inﬂuenced by the presence
of sleep disorders such as sleep apnea or of factors that
inﬂuence the aspect of sleep physiology measured by a home
monitor. For example, an actigraphy device would need
to be separately validated in patients with versus without
intrinsic movement disorders (such as Parkinson’s disease).
Ideally, validations should include a spectrum of subject
characteristics (age, sex, BMI, and health status), to improve
the generality of use.
The American Academy of Sleep Medicine scoring
criteria utilizes a time interval of 30 seconds to deﬁne an
epoch of sleep, with a “majority rules” approach to assigning
a stage to an epoch that contains features of more than
one stage [37]. Thus, if a device utilizes a time interval
that is either shorter or longer than the AASM criteria, the
validation results may diﬀer. For example, shorter epochs
may capture nuances of sleep architecture, while longer
epochs or smoothing algorithms may yield a diﬀerent image
of sleep physiology.
It is worth mentioning that the term “accuracy” may
carry several meanings. The standard manner of reporting
diagnostictestsinmedicineinvolvesthesensitivityandspeci-
ﬁcity when tested against a gold standard. In diagnostic tests,
typicallyoneconsidersadiseasetobeeitherpresentorabsent
and a test result to be either positive or negative. In that
setting, sensitivity refers to the portion of patients with the
disease who test positive and speciﬁcity refers to the portion
of patients without the disease who test negative. Accuracy
is a term that incorporates sensitivity and speciﬁcity but is
strongly dependent on the actual number of disease versus
healthy individuals being tested (i.e., the prevalence or prior
probability of disease). Speciﬁcally, accuracy refers to the
sum of true positives and true negatives divided by all tested
subjects. In the measurement of sleep, one can consider the
analysis framework as follows: instead of disease presence
versus absence, the diagnostic device indicates the presence
or absence of sleep. For example, the portion of true sleep
epochs (deﬁned, e.g., by PSG) that are correctly classiﬁed by8 ISRN Neurology
a device as sleep can be called the device sensitivity, while the
portion of true wake epochs correctly classiﬁed by a device
as wake can be called the device speciﬁcity. If the recording
time were split evenly between wake and sleep (50% each),
one could interpret the accuracy because the evenly divided
time avoids a prevalence bias in the expected number of true
positives and true negatives. However, for most individuals,
wake is such a small part of time in bed that the composite
accuracy metric may be dominated by the sensitivity of
the device, especially if sensitivity and speciﬁcity values are
dissimilar. Put another way, if test subjects sleep >95% of
time in bed, a device can report high accuracy if it can
correctly identify sleep epochs most of the time even if it
labels most wake periods as sleep (but the opposite is not
true).
7.5. A Comment on “Normal Sleep”. Although it is com-
monly stated that the average number of hours of sleep
needed by an adult is 8 hours, sleep duration requirements
depend on many factors, and there may be a wide spectrum
of acceptable sleep physiology in humans. Normative sleep
stage data has been published from large data sets [38], but
thesestudiestypicallyfocusonwhatiscalledsummarystatis-
tics, such as the percentage of time spent in various sleep-
wake stages in the night. This coarse view does not capture
much of the rich physiology of sleep. For example, sleep
apnea is known to fragment or interrupt REM sleep in many
individuals(whetherthisﬁndingrelatestoclinicalsymptoms
remains unproven). If one measures the percentage of the
night spent in REM sleep in people with severe sleep apnea
versusnosleepapnea,thereislittleornodiﬀerence;however,
if the time spent in REM sleep is measured through more
appropriate methods, called transition analysis, there is clear
evidence of fragmentation [39–41]. This concept applies to
time spent in any sleep-wake stage, and there is growing
evidence that alternative metrics for quantifying sleep-wake
stage architecture provide unique insights and may prove
more relevant for subjective and medical endpoints than the
traditional summary statistics.
Despitetheattractiveideathatcertainaspectsofsleepare
more or less important than others for us to feel refreshed
and performing optimally, many challenges remain. For
example, the “sleep cycle” length of approximately 90 min-
utes of alternation between REM and NREM sleep is variable
from night to night, and thus that pattern may only be
evident upon averaging across multiple nights. The amount
of time spent in REM sleep may vary depending on disease
states (like sleep apnea), medications (like antidepressants),
or alcohol ingestion. Many medications used for sleep have
been shown to suppress REM and slow wave sleep and yet
may improve the subjective impression of sleep in some
individuals. It is important to recognize that much remains
unknown in terms of what is normal or optimal, and the
answers (if they can be surmised) may even diﬀer from
individual to individual. Perhaps the most striking example
of individual variability in sleep involves the symptoms of
sleep apnea, the best described and most dramatic source
of sleep disturbance in the ﬁeld of sleep medicine. Only
half of individuals with severe sleep apnea have daytime
sleepiness, whether assessed by subjective report or by
objective measurement [42]. The use of home monitoring
may allow individuals to attempt to identify patterns of
interest that correlate with their own subjective sense.
However, caution should be exercised when the output of
sleep monitors overlaps with widely held concepts that have
little clinical basis (e.g., “The device says I’m not getting
enough REM sleep,”) and thus may introduce distractions
from self-discovery.
7.6. A Comment on Smart Alarms. There is clearly a sense of
“face validity” for the concept of an alarm clock allowing one
to wake up at the optimal time, that is, when sleep is already
lightest. Face validity refers to situations in which a concept
is so obvious as to obviate the need for validation data.
Unfortunately, the history of biomedical research teaches
us that most ideas initially felt to have face validity do not
withstand the test of rigorous experimentation. Smart alarm
claims are not new, and patents based on the idea that one
should ideally awaken at a time of light sleep date back over
20years.Thelackofdataisconcerning,giventhatthisfeature
is no doubt an important attraction to potential consumers.
In fact, how the stage of sleep from which one awakens
impactssubjectivealertnessremainslargelyunknown.Itmay
be the case that waking from deep, N3 sleep is more diﬃcult
and some people may experience sleep inertia when aroused
from this stage, and thus alarms that tend to detect periods
when one is less likely to be in this stage may be beneﬁcial
in terms of avoiding sleep inertia. Testing this would be
fairly straightforward. For example, a trial could involve 1-2
weeks of monitoring, in which each morning is randomized
to either alarm at the supposedly “optimal” time or at a
nonoptimal time. The subject would be blinded to this and
would only report their level of alertness upon awakening
or how refreshing their sleep was. In this way, one could
determine whether the smart-alarm feature was actually
serving some beneﬁt at the individual level. Unfortunately,
such a trial has not been done, despite multiple devices
claiming a smart alarm feature.
7.7. Concluding Comments on a Research Agenda. The most
common measurement technique in the wellness arena is
limb movement. Most commercial devices using actigraphy
do not have available validation studies. This is a critical
limitation given the widespread use of these devices in
the wellness arena due to their ease of measurement and
simple graphical display of data. It is insuﬃcient to refer,
as some devices do, to the rich literature of research-
grade wrist actigraphy for two reasons: one is that each
device has nuances of movement detection and analysis that
cannot be assumed to generalize, and the other is that wrist
actigraphyhasenjoyedonlylimitedclinicaluse.Forexample,
actigraphy is mainly used to assess gross sleep-wake patterns
over long periods of time in the assessment of circadian
rhythm disorders, and in research studies to ensure certain
sleep-wake schedules are being adhered to for experimental
validity. It is not used to determine sleep stages and isISRN Neurology 9
rarely used as a measure of sleep quality outside of research
studies. Thus, while the idea that movement-based analysis
might prove useful for individuals performing longitudinal
tracking is interesting, the limitations of this method should
be appreciated.
The pace of research studies seems to be lagging behind
the pace of advertising in the ﬁeld of home sleep monitors.
The M1 device has undergone research in medical contexts
and has clearance for use by physicians. Of the products
targeting the consumer wellness market, the Zeo headband
has published validation data but has not been validated
in those with sleep problems (such as insomnia), medical
illness, or exposures (medications, alcohol, caﬀeine), any of
which might alter the measured signals and thus confound
the built-in analysis. For example, many antidepressant
medications are known to alter several aspects of sleep-
physiology, including muscle tone, eye movements, and EEG
rhythms. This is a common problem in general in medical
trials: the conclusions may only be relevant for the speciﬁc
population under the speciﬁc conditions of the study. In
other words, generalizing the ﬁndings of any study to a
broader population should be undertaken with caution. It
is possible that future developments using analysis of raw
data will clarify the strengths and weaknesses of various
devices with respect to particular populations. We suggest
that the diversity of methods being marketed for sleep
monitoring should be subjected to formal validation studies
across a spectrum of populations most likely to beneﬁt, as
the algorithms and validity may diﬀer by population. This
will be crucial to understand monitoring limitations as well
as to maximize the utility of the time and money invested in
self-tracking.
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